Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Covey

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer InstituteG J Kelloff, J A Crowell, C W Boone, et al.
Biochemical Pharmacology|October 6, 1999
Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agentD L Walker, J M Reid, P A Svingen, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Strategy and planning for chemopreventive drug development: clinical development plans IIG J Kelloff, J A Crowell, E T Hawk, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer InstituteG J Kelloff, J A Crowell, C W Boone, et al.
Biochemical Pharmacology|October 6, 1999
Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agentD L Walker, J M Reid, P A Svingen, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Strategy and planning for chemopreventive drug development: clinical development plans IIG J Kelloff, J A Crowell, E T Hawk, et al.
Pageof 4